Supply Chain Wake-Up Call: Rare Earths, Pharmaceuticals, and Policy Challenges
In recent years, the United States has faced a wake-up call regarding its dependence on foreign sources for key industrial and pharmaceutical materials. The pandemic highlighted critical vulnerabilities, particularly in the pharmaceutical industry, where access to essential medications and raw materials proved alarmingly fragile. Much of that supply originated in China, underscoring the need to























